Labiotech.eu - Europe's leading Biotech News Website

Don't miss out on the next big biotech breakthrough

Get all the latest updates straight into your inbox!

Newsletter Signup - Home CTA

"*" indicates required fields

News and Trends
December 1, 2023
Arvinas raises $350 million; Exonate’s trial reaps success; new cancer drugs discovered
Podcast
December 1, 2023
Ipsen drug gives hope for liver disease patients
In Depth
November 30, 2023
Could an Alzheimer’s vaccine make treatment more affordable?
Best in Biotech
November 28, 2023
Five companies shaping Texas’ growing biotech hubs

Beyond Biotech - the podcast from Labiotech

View More

Latest Posts
Popular Posts

Opinion 29 Nov 2023
Redefining drug development: the trailblazing evolution of the pharmaceutical industry
Drug discovery and development is a long, costly, and high-risk process that takes over 10 to 15 years with an average cost of over $1 to $2 billion for each…
November 29, 2023 - 9 minutesmins - By External Contributor

WhatsApp
Twitter
Linkedin
Email
Sponsored by Indivumed Therapeutics
28 Nov 2023
Standardizing tissue quality: Your key to accurate early discovery insights
In precision oncology, tissue quality plays a pivotal role in maintaining data integrity. We explore the impact of standardizing tissue collection and processing on data quality, and how this helps…
November 28, 2023 - 8 minutesmins - By Sudha Sundaram

WhatsApp
Twitter
Linkedin
Email
In Depth 27 Nov 2023
How are R&D Tax Incentives shaping Australia’s biotech future?
Research and development (R&D) stands as a cornerstone for driving innovation, particularly within the biotech industry. The pivotal role of R&D extends beyond immediate commercial implications and encompasses a broader…
November 27, 2023 - 5 minutesmins - By Jules Adam

WhatsApp
Twitter
Linkedin
Email
Weekly Roundup 24 Nov 2023
Viva’s $210 million round; Merck grabs Caraway for $610 million; Genentech signs a deal with NVIDIA
Here is Labiotech’s weekly roundup of the latest biotech news. Whether it is partnerships, clinical trials, or fundraising, we have got you covered. Stay in the loop by subscribing to…
November 24, 2023 - 14 minutesmins - By Roohi Mariam Peter

WhatsApp
Twitter
Linkedin
Email
ADVERTISEMENT
Podcast 24 Nov 2023
Company exits stealth to launch molecular gates
On this week’s podcast we have a conversation with Jordi Mata-Fink, co-founder and chief executive officer of Gate Bioscience. Gate Bioscience is a U.S.-based biotechnology company creating a new class…
November 24, 2023 - 5 minutesmins - By Jim Cornall

WhatsApp
Twitter
Linkedin
Email
In Depth 23 Nov 2023
The next frontier in immunotherapy? CAR-Macrophages as a novel cancer treatment strategy
Immunotherapy has revolutionized cancer treatment, offering promising avenues beyond traditional methods. Recent breakthroughs showcased at the Society for Immunotherapy of Cancer’s (SITC) annual meeting have spotlighted innovative approaches, notably chimeric…
November 23, 2023 - 5 minutesmins - By Jules Adam

WhatsApp
Twitter
Linkedin
Email
ADVERTISEMENT
Sponsored by 2 Bridge
23 Nov 2023
How tiger teams are transforming the life sciences startup landscape
The life sciences ecosystem is facing a critical moment of transformation, driven by a new generation of startups that adopt a novel approach to scaling up. Unwilling to conform to…
November 23, 2023 - 4 minutesmins - By External Contributor

WhatsApp
Twitter
Linkedin
Email
In Depth 22 Nov 2023
Apellis’ Syfovre vs Astellas’ Izervay: the battle for a geographic atrophy treatment
Until the approval of Apellis’ Syfovre earlier this year, there was no treatment for geographic atrophy. Shortly after, Astellas’ Izervay was also approved for the eye condition. Now, as the…
November 22, 2023 - 8 minutesmins - By Willow Shah-Neville

WhatsApp
Twitter
Linkedin
Email
Outsourcing in life science R&D today

Get your free download now
Best in Biotech 21 Nov 2023
Beyond insulin: six cutting-edge diabetes biotech companies you should know about
As we predicted last year, the diabetes market is booming, particularly after the incredible success of new diabetes drugs like Novo Nordisk’s Ozempic and Eli Lilly’s Mounjaro. There are now…
November 21, 2023 - 7 minutesmins - By Willow Shah-Neville

WhatsApp
Twitter
Linkedin
Email
News and Trends 20 Nov 2023
M&As: what’s up with the ADC buying spree?
Antibody drug conjugates (ADCs) have been much sought-after through investments of late, with big pharma eyeing these drugs developed by various biotechs, to eventually nab them. With yet another ADC…
November 20, 2023 - 7 minutesmins - By Roohi Mariam Peter

WhatsApp
Twitter
Linkedin
Email
News and Trends 17 Nov 2023
With $700 million Q3 rise, U.K. biotech spearheads European recovery
The U.K.'s biotechnology landscape has witnessed an impressive surge in funding, clocking a robust £563 million ($700 million) in venture capital and public financings in the third quarter of 2023,…
November 17, 2023 - 4 minutesmins - By Jules Adam

WhatsApp
Twitter
Linkedin
Email
Podcast 17 Nov 2023
How can life-saving vaccines be more affordable?
Phenotypeca, a biotech business from Nottingham, UK, has been working with the Bill & Melinda Gates Foundation to produce albumin for low and middle-income countries (LMICs), offering a catalyst for…
November 17, 2023 - 8 minutesmins - By Jim Cornall

WhatsApp
Twitter
Linkedin
Email
In Depth 22 Jun 2023
Brace yourself for a wave of biotech layoffs
In the ever-evolving field of biotechnology spearheaded by discoveries that fuel therapeutic success, of late, the industry is taking measures to optimize the workforce amid economic uncertainty. Or to put…
June 22, 2023 - 6 minutesmins - By Roohi Mariam Peter
WhatsApp
Twitter
Linkedin
Email
Best in Biotech 4 Jul 2023
Six biotech spinouts you should watch out for this year
Academic spinouts are companies that are typically formed from research taking place at academic institutions and are sometimes launched and owned by the university. A means to turn research into…
July 4, 2023 - 8 minutesmins - By Roohi Mariam Peter
WhatsApp
Twitter
Linkedin
Email
In Depth 10 Jul 2023
This biotech startup is making an impact through targeting mRNA
Biotech company Molecure develops small molecule therapies that can regulate RNA and underexplored protein targets for the treatment of incurable diseases, including cancer and fibrotic and inflammatory diseases. The company,…
July 10, 2023 - 7 minutesmins - By Jim Cornall
WhatsApp
Twitter
Linkedin
Email
Best in Biotech 28 Jul 2023
Six biotech companies changing the game in Chennai
Just like Bangalore, the city of Chennai in the southern state of Tamil Nadu in India, is a key hub for the biotech industry in the country. Chennai, which runs…
July 28, 2023 - 7 minutesmins - By Roohi Mariam Peter
WhatsApp
Twitter
Linkedin
Email
Best in Biotech 30 May 2023
Five latest advancements in endometriosis research
Affecting around 190 million women and girls globally, endometriosis is caused by the growth of tissue - similar to those in the uterine lining - outside the uterus, leading to…
May 30, 2023 - 9 minutesmins - By Roohi Mariam Peter
WhatsApp
Twitter
Linkedin
Email
Best in Biotech 22 Mar 2023
6 cultured meat companies making waves
An unsustainable demand for meat has led to companies looking for alternative solutions to conventional farming methods in order to change the way we eat and think about meat. For…
March 22, 2023 - 8 minutesmins - By Willow Shah-Neville
WhatsApp
Twitter
Linkedin
Email
In Depth 3 Mar 2023
7 rare autoimmune diseases Biotechs are Fighting to Treat
While we mostly think of disease as being caused by bacteria or viruses, an illness can often occur when the body’s own defenses turn against itself. Here we’ll take a…
March 3, 2023 - 8 minutesmins - By Alexander Burik
WhatsApp
Twitter
Linkedin
Email
In Depth 1 Dec 2022
Is an HIV Cure Possible? The Future of HIV Therapy
HIV research has come a long way since the virus was discovered in the 1980s. Antiretroviral therapy was a major milestone that has changed the lives of millions; the goal…
December 1, 2022 - 8 minutesmins - By Clara Rodríguez Fernández
WhatsApp
Twitter
Linkedin
Email
Best in Biotech 12 Apr 2023
6 new vaccines in development for difficult-to-treat diseases
There are several promising new vaccine candidates being developed for complex diseases that historically have been extremely difficult to find treatments and cures for. The development of these new vaccines…
April 12, 2023 - 10 minutesmins - By Willow Shah-Neville
WhatsApp
Twitter
Linkedin
Email
Best in Biotech 1 Aug 2023
The top biotech books of all time every science lover should read
It’s summertime and what’s better than to curl up in bed, or under a shady tree, or by the pool, and read a good book? We have curated a list…
August 1, 2023 - 19 minutesmins - By Roohi Mariam Peter
WhatsApp
Twitter
Linkedin
Email
News and Trends 13 Apr 2023
Parkinson's cure 'inevitable' after biomarker breakthrough
The Michael J. Fox Foundation for Parkinson's Research (MJFF) has announced what it says is the ‘most significant breakthrough yet’ in the search for a Parkinson's biomarker: a biological test…
April 13, 2023 - 7 minutesmins - By Jim Cornall
WhatsApp
Twitter
Linkedin
Email
Best in Biotech 1 Dec 2022
At home HIV tests: 5 promising apps in development in 2022
The smartphone revolution is providing a promising tool to combat the human immunodeficiency virus (HIV) epidemic. We’ve listed five HIV test apps in development that could help people carry out…
December 1, 2022 - 8 minutesmins - By Jonathan Smith
WhatsApp
Twitter
Linkedin
Email

Beyond Biotech - the podcast from Labiotech

View More

Newsletter Signup - Sidebar

"*" indicates required fields

Want to advertise with us?

Reach us here!

Got a news story for us?

Send it to us here